Re:Biopharma has abandoned antibiotic development
by Starkus on Monday December 16, 2019 @04:18PM
(#21807298)
Ah, reminds me of investing (poorly) in Amplify Biosciences in late 2017...
Since acquired by Armata pharma, which trades around 4 a share, cap of 40M.... I lost 90% of my investment, oh darn, was a bad investment in hindsight.
Looking at that chart in the article, not too surprised the rest of the market in big red territory.
Since acquired by Armata pharma, which trades around 4 a share, cap of 40M.... I lost 90% of my investment, oh darn, was a bad investment in hindsight.
Looking at that chart in the article, not too surprised the rest of the market in big red territory.